These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Incidence of peptic ulcer in hospital practice with observations on the effects of an anticholinergic drug (oxyphenonium bromide). DEY MK; MUKERJEE AB; SARKAR S J Indian Med Assoc; 1956 Aug; 27(3):90-5. PubMed ID: 13367422 [No Abstract] [Full Text] [Related]
27. [Isolated demonstration of the duodenum in Antrenyl hypotony]. Moldenhauer W; Kröger W; Schultz J Rontgenpraxis; 1967 May; 20(5):101-10. PubMed ID: 4970424 [No Abstract] [Full Text] [Related]
28. Clinical and experimental observations in peptic ulcer with a new, prolonged-acting anticholinergic drug. SHUTKIN MW Am J Gastroenterol; 1958 Jun; 29(6):585-92; discussion 592-5. PubMed ID: 13533382 [No Abstract] [Full Text] [Related]
29. Inhibition of ulcer formation in the Shay rat and reduction of gastric acidity in dogs by antrenyl (oxyphenonium) (BA5473) diethyl(2-hydroxyethyl)methylammonium bromide alpha-phenyl-cyclohexaneglycolate, an anticholinergic agent. BARRETT WE; RUTLEDGE R; PLUMMER AJ; YONKMAN FF J Pharmacol Exp Ther; 1953 Jul; 108(3):305-16. PubMed ID: 13070149 [No Abstract] [Full Text] [Related]
30. [The treatment of acute diarrheas in infants by granulated Mexaforme]. Sansot M; Taramasco ; Chabert Mars Med; 1967; 104(3):295-300. PubMed ID: 4229651 [No Abstract] [Full Text] [Related]
31. [Studies on the 24 hour urinary excretion of 5-hydroxyindoleacetic acid in patients with stomach or duodenal ulcer before, during and after treatment with Spasmophen in relation to the "basal HC1 excretion" and the clinical condition of patients]. Czarnecki J Pol Arch Med Wewn; 1968 Jun; 40(6):683-9. PubMed ID: 4970763 [No Abstract] [Full Text] [Related]
32. [Duodenography in anthrenyl hyptonia]. Walter LW; Teichmann W Fortschr Geb Rontgenstr Nuklearmed; 1968 Oct; 109(4):516-25. PubMed ID: 4974658 [No Abstract] [Full Text] [Related]
33. Anticholinergic drugs in the management of duodenal ulcer. Amure BO Practitioner; 1965 Sep; 195(167):335-9. PubMed ID: 4378437 [No Abstract] [Full Text] [Related]
34. [Use of bispan in ulcer disease]. Galetskaia TM; Mironova KA; Okhonko VI; Spivak AM; Fomina AA Vrach Delo; 1975 Jan; (1):15-8. PubMed ID: 237368 [No Abstract] [Full Text] [Related]
35. [Anticholinergics and cytoprotectants in gastroduodenal ulcer]. Bernardi P; Fidanza F; Mancini L; Pace V Riv Eur Sci Med Farmacol; 1993; 15(2):99-105. PubMed ID: 8171220 [TBL] [Abstract][Full Text] [Related]
36. [Kinetics of hydrolysis of oxyphenonium bromide]. Grabowska I Acta Pol Pharm; 1971; 28(3):305-9. PubMed ID: 4999177 [No Abstract] [Full Text] [Related]
37. [Clinical trials of a combination of an original gastric demulcent and a synthetic anticholinergic agent]. Evreux M; Jenoudet L Lyon Med; 1972 Jun; 227(11):1181-4. PubMed ID: 4564809 [No Abstract] [Full Text] [Related]
38. [Use of a synthetic anticholinergic in the treatment of gastroduodenal ulcer and hypersecretory gastritis; benzomethamine hydrochloride]. TAMPIERI A Minerva Med; 1956 Mar; 47(22):754-6. PubMed ID: 13333995 [No Abstract] [Full Text] [Related]
39. [Studies on resolution of oxyphenonium bromide and products of its hydrolysis]. Grabowska I Acta Pol Pharm; 1971; 28(1):49-53. PubMed ID: 4996052 [No Abstract] [Full Text] [Related]
40. Excretion of 5-hydroxyindoleacetic acid in patients with duodenal ulcer and spastic colitis after administration of certain anticholinergic drugs. Pokora J; Tuszkiewicz AR; Czarnecki J; Matuszewski M Pol Med J; 1968; 7(1):61-5. PubMed ID: 5650203 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]